Quantcast

Latest Abiraterone Stories

2011-06-03 06:30:00

CHICAGO, June 3, 2011 /PRNewswire/ -- Data related to ZYTIGA(TM) (abiraterone acetate) will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The studies were sponsored by Ortho Biotech Oncology Research & Development, unit of Cougar Biotechnology, Inc. "We are pleased that these data have been selected for presentation at the 2011 ASCO Annual Meeting," said William N. Hait, M.D., Ph.D., Global Therapeutic Area Head, Ortho Biotech...

2011-05-26 15:14:20

New therapy tolerated well by most patients A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time.  A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months. The study in the May 26, 2011 issue of the New England Journal of Medicine was co-authored by Thomas W. Flaig, MD, medical oncologist at the University of Colorado...

2011-05-25 16:26:00

HORSHAM, Pa., May 25, 2011 /PRNewswire/ -- A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA(TM) (abiraterone acetate) plus prednisone compared to patients treated with prednisone plus placebo. The COU-AA-301...

2011-04-28 14:04:00

HORSHAM, Pa., April 28, 2011 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ZYTIGA(TM) (abiraterone acetate), an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel. Androgens are hormones that promote the development and maintenance of male sex characteristics....

2011-04-28 13:40:00

SILVER SPRING, Md., April 28, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) In prostate cancer, the male sex hormone testosterone stimulates prostate tumors to grow. Drugs or surgery are...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related